Emerald Advisers’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-147,280
| Closed | -$6.57M | – | 332 |
|
|
2020
Q1 | $6.57M | Sell |
147,280
-232,508
| -61% | -$10.4M | 0.38% | 90 |
|
|
2019
Q4 | $18.2M | Buy |
379,788
+7,880
| +2% | +$378K | 0.77% | 50 |
|
|
2019
Q3 | $12.6M | Sell |
371,908
-16,102
| -4% | -$545K | 0.59% | 71 |
|
|
2019
Q2 | $17.5M | Buy |
388,010
+88,579
| +30% | +$3.99M | 0.7% | 55 |
|
|
2019
Q1 | $11.3M | Buy |
299,431
+77,928
| +35% | +$2.93M | 0.46% | 83 |
|
|
2018
Q4 | $7.6M | Sell |
221,503
-3,947
| -2% | -$135K | 0.37% | 92 |
|
|
2018
Q3 | $10.6M | Buy |
+225,450
| New | +$10.6M | 0.39% | 104 |
|
|
2016
Q1 | – | Sell |
-137,524
| Closed | -$4.46M | – | 329 |
|
|
2015
Q4 | $4.46M | Buy |
137,524
+115,010
| +511% | +$3.73M | 0.21% | 136 |
|
|
2015
Q3 | $601K | Buy |
+22,514
| New | +$601K | 0.03% | 287 |
|